A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma. - Subramani, Baskaran; Conway, Patrick J.; Al-Khinji, Aisha; Zhang, Kun; Pandey, Ritu; Mahadevan, Daruka (Cancers, 2024)